Pran Marrott

1.2k total citations
7 papers, 682 citations indexed

About

Pran Marrott is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pran Marrott has authored 7 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pran Marrott's work include Angiogenesis and VEGF in Cancer (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Pran Marrott is often cited by papers focused on Angiogenesis and VEGF in Cancer (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Pran Marrott collaborates with scholars based in United Kingdom, United States and New Zealand. Pran Marrott's co-authors include Cindy L. Grines, Matthew W. Watkins, Jeffrey J. Rade, Andrew B. West, Neal S. Kleiman, Jonathan D. Marmur, Robert L. Engler, H. Kirk Hammond, William F. Penny and Jeffrey Brinker and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Pran Marrott

7 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pran Marrott United Kingdom 7 429 248 196 165 66 7 682
Rebecca T Hahn United States 7 258 0.6× 148 0.6× 263 1.3× 75 0.5× 45 0.7× 16 527
Mohamad Amer Alaiti United States 9 449 1.0× 130 0.5× 199 1.0× 40 0.2× 20 0.3× 28 719
Aiqiang Dong China 15 209 0.5× 97 0.4× 128 0.7× 47 0.3× 37 0.6× 50 667
You-Ying Chau United Kingdom 13 488 1.1× 192 0.8× 185 0.9× 66 0.4× 14 0.2× 18 954
Joakim Sandstedt Sweden 15 231 0.5× 234 0.9× 161 0.8× 51 0.3× 24 0.4× 38 581
Xiaoli Ma Canada 14 286 0.7× 187 0.8× 94 0.5× 28 0.2× 33 0.5× 25 544
F. M. van Bockxmeer Australia 14 155 0.4× 91 0.4× 117 0.6× 44 0.3× 12 0.2× 20 573
Mahboubeh Eghbali-Webb United States 11 194 0.5× 80 0.3× 221 1.1× 51 0.3× 22 0.3× 14 458
Jochen Pöling Germany 13 448 1.0× 260 1.0× 369 1.9× 35 0.2× 17 0.3× 29 876
Zhihua Jiang United States 15 212 0.5× 228 0.9× 133 0.7× 45 0.3× 42 0.6× 33 578

Countries citing papers authored by Pran Marrott

Since Specialization
Citations

This map shows the geographic impact of Pran Marrott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pran Marrott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pran Marrott more than expected).

Fields of papers citing papers by Pran Marrott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pran Marrott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pran Marrott. The network helps show where Pran Marrott may publish in the future.

Co-authorship network of co-authors of Pran Marrott

This figure shows the co-authorship network connecting the top 25 collaborators of Pran Marrott. A scholar is included among the top collaborators of Pran Marrott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pran Marrott. Pran Marrott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Grines, Cindy L., Gabor M. Rubanyi, Neal S. Kleiman, Pran Marrott, & Matthew W. Watkins. (2003). Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. The American Journal of Cardiology. 92(9). 24–31. 43 indexed citations
2.
Grines, Cindy L., Matthew W. Watkins, John J. Mahmarian, et al.. (2003). A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. Journal of the American College of Cardiology. 42(8). 1339–1347. 195 indexed citations
3.
Grines, Cindy L., Matthew W. Watkins, William F. Penny, et al.. (2002). Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris. Circulation. 105(11). 1291–1297. 366 indexed citations
4.
Marrott, Pran, et al.. (1984). Idiopathic infantile arterial calcification with survival to adult life. Pediatric Cardiology. 5(2). 119–122. 44 indexed citations
5.
Franklin, Richard A., et al.. (1984). Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers. European Journal of Clinical Pharmacology. 27(2). 247–249. 11 indexed citations
6.
Franklin, Richard A., et al.. (1983). Pharmacokinetics of intravenous indoramin in middle-aged male and female volunteers. European Journal of Clinical Pharmacology. 25(2). 243–246. 9 indexed citations
7.
Holmes, Alan, et al.. (1970). Pseudohyperaldosteronism induced by habitual ingestion of liquorice. Postgraduate Medical Journal. 46(540). 625–629. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026